At the time of writing, GlycoMimetics Inc [GLYC] stock is trading at $0.22, up 9.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GLYC shares have gain 25.92% over the last week, with a monthly amount drifted -15.81%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, TD Cowen downgraded its rating to Hold on July 26, 2024. On December 22, 2023, CapitalOne initiated with a Overweight rating and assigned a price target of $12 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $4 on November 12, 2021. ROTH Capital initiated its recommendation with a Buy and recommended $12 as its price target on November 14, 2019. SunTrust downgraded its rating to Hold for this stock on August 05, 2019, and downed its price target to $5. In a note dated August 05, 2019, Piper Jaffray downgraded an Neutral rating on this stock and revised its target price from $20 to $6.
For the past year, the stock price of GlycoMimetics Inc fluctuated between $0.14 and $2.53. GlycoMimetics Inc [NASDAQ: GLYC] shares were valued at $0.22 at the most recent close of the market.
Analyzing the GLYC fundamentals
According to GlycoMimetics Inc [NASDAQ:GLYC], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -3.42, Equity is -2.31 and Total Capital is -7.54. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2039 points at the first support level, and at 0.1858 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2339, and for the 2nd resistance point, it is at 0.2458.
Ratios To Look Out For
It is important to note that GlycoMimetics Inc [NASDAQ:GLYC] has a current ratio of 1.92. In addition, the Quick Ratio stands at 1.92 and the Cash Ratio stands at 1.86.
Transactions by insiders
Recent insider trading involved Invus Public Equities, L.P., 10% Owner, that happened on Aug 08 ’24 when 0.26 million shares were sold. 10% Owner, Invus Public Equities, L.P. completed a deal on Aug 07 ’24 to sell 61488.0 shares. Meanwhile, 10% Owner Invus Public Equities, L.P. sold 0.16 million shares on Aug 05 ’24.
